A new review explored using partial tandem duplication levels from the MLL gene to monitor for minimal residual disease (MRD) status to predict disease relapse following allogeneic hematopoietic stem ...
A review looks at techniques to monitor minimal residual disease (MRD) in patients with multiple myeloma (MM). “In most patients, the cause of the relapse is residual drug-resistant MM cells,” the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback